Search by Drug Name or NDC
NDC 68462-0576-01 Benazepril Hydrochloride and Hydrochlorothiazide 5; 6.25 mg/1; mg/1 Details
Benazepril Hydrochloride and Hydrochlorothiazide 5; 6.25 mg/1; mg/1
Benazepril Hydrochloride and Hydrochlorothiazide is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Glenmark Pharmaceuticals Inc., USA. The primary component is BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE.
MedlinePlus Drug Summary
The combination of benazepril and hydrochlorothiazide is used to treat high blood pressure. Benazepril is in a class of medications called angiotensin-converting enzyme (ACE) inhibitors. It works by decreasing certain chemicals that tighten the blood vessels, so blood flows more smoothly. Hydrochlorothiazide is in a class of medications called diuretics ('water pills'). It works by causing the kidneys to get rid of unneeded water and salt from the body into the urine. High blood pressure is a common condition, and when not treated it can cause damage to the brain, heart, blood vessels, kidneys, and other parts of the body. Damage to these organs may cause heart disease, a heart attack, heart failure, stroke, kidney failure, loss of vision, and other problems. In addition to taking medication, making lifestyle changes will also help to control your blood pressure. These changes include eating a diet that is low in fat and salt, maintaining a healthy weight, exercising at least 30 minutes most days, not smoking, and using alcohol in moderation.
Related Packages: 68462-0576-01Last Updated: 04/28/2024
MedLinePlus Full Drug Details: Benazepril and Hydrochlorothiazide
Product Information
| NDC | 68462-0576 |
|---|---|
| Product ID | 68462-576_51b0aed8-a229-4d2c-8fdf-aa957fddc41b |
| Associated GPIs | |
| GCN Sequence Number | 021723 |
| GCN Sequence Number Description | benazepril/hydrochlorothiazide TABLET 5-6.25MG ORAL |
| HIC3 | A4J |
| HIC3 Description | ACE INHIBITOR-THIAZIDE OR THIAZIDE-LIKE DIURETIC |
| GCN | 33191 |
| HICL Sequence Number | 008962 |
| HICL Sequence Number Description | BENAZEPRIL HCL/HYDROCHLOROTHIAZIDE |
| Brand/Generic | Generic |
| Proprietary Name | Benazepril Hydrochloride and Hydrochlorothiazide |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Benazepril Hydrochloride and Hydrochlorothiazide |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, FILM COATED |
| Route | ORAL |
| Active Ingredient Strength | 5; 6.25 |
| Active Ingredient Units | mg/1; mg/1 |
| Substance Name | BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE |
| Labeler Name | Glenmark Pharmaceuticals Inc., USA |
| Pharmaceutical Class | Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA076631 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 68462-0576-01 (68462057601)
| NDC Package Code | 68462-576-01 |
|---|---|
| Billing NDC | 68462057601 |
| Package | 100 TABLET, FILM COATED in 1 BOTTLE (68462-576-01) |
| Marketing Start Date | 2023-12-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |